Leading domestic manufacturer of nucleotide and amino acid products. Mainly engaged in food and feed additives business and biochemical raw materials business. At present, the company has a production capacity of 10000 tons of nucleotide additives and 4094 tons of biochemical raw materials and intermediates.
Two. Saisheng Pharmaceutical: In the third quarter of 20021,the company achieved total revenue of 343 million, gross profit margin of 68.07%, and earnings per share of 0. 1 100 yuan.
After years of technical accumulation, the company's R&D and production team have established a professional technical platform for the separation and purification of biomacromolecules such as protein (polypeptide), polysaccharide, nucleotide and functional lipid.
Three. Jinhua shares: In the third quarter of 2002/kloc-0, the company achieved total revenue of 654.38+49 million, gross profit margin of 76.57% and earnings per share of 0.0 165 yuan.
Jinhua brand transfer factor oral liquid/capsule is a pure bioactive factor extracted by high-tech biological separation technology. Its main components are small molecular peptides and nucleotides. It is an efficient two-way immunomodulator, which can transmit immune information, activate immune cells, enhance or inhibit humoral immunity and cellular immunity, and increase the number of helper T cells. Can be used for treating viral infection and autoimmune diseases.
4. Meihua Bio: According to the quarterly report of 20021third quarter, Meihua Bio achieved total revenue of 5.258 billion yuan, with earnings per share of 0. 1 100 yuan.
One of the world's leading producers of monosodium glutamate, China ranks second and China is the largest producer of amino acids; 19 years, we sold 61.10.00 billion yuan of food flavor and shape optimization products (including monosodium glutamate and flavored nucleotide disodium), accounting for 42% of the main products.
Verb (abbreviation of verb) China Resources Shuanghe: The company's total revenue in the third quarter of 2002/kloc-0 was 2.245 billion, with a gross profit margin of 57.05% and earnings per share of 0.2822 yuan.
The company produces nicotinamide raw materials, not drugs themselves, and it is one of the raw materials for preparing NMN(β- nicotinamide mononucleotide) by chemical method.